Therapeutic area

Metabolism and nutrition disorders – page 57

741 clinical trials
260 recruiting
237 conditions
26 countries

Clinical trials in Metabolism and nutrition disorders

741 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

741 clinical trials

Obesity+1

Not recruiting

Registered drug

Study on the Safety and Effects of AZD9550 for Overweight and Obese Patients with Non-Alcoholic Steatohepatitis (NASH) with or without Type 2 Diabetes

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid
Sponsor:AstraZeneca AB

Contact Research Centre

Obesity+2

Not recruiting

Investigational

Study of Retatrutide (LY3437943) for Patients with Obesity or Overweight and Knee Osteoarthritis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Ly3437943 Sodium
Sponsor:Eli Lilly & Co.

Contact Research Centre

Type 2 diabetes mellitus+2

Not recruiting

Investigational

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Investigational

Czechia

Participants:18–64 years · 65+ years
Sponsor:Eli Lilly & Co.

Contact Research Centre

Diabetic retinal oedema

Not recruiting

Investigational

Study on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:Oculis Operations SARL

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Registered drug

Study on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes

Registered drug

Belgium

Participants:18–64 years
Substances:Paracetamol
Sponsor:Itb-Med AB

Contact Research Centre

Hyperparathyroidism secondary

Not recruiting

Investigational

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Upacicalcet Sodium Hydrate
Sponsor:Pathalys Pharma Inc.

Contact Research Centre

Hyperparathyroidism secondary

Not recruiting

Investigational

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Upacicalcet Sodium Hydrate
Sponsor:Pathalys Pharma Inc.

Contact Research Centre

Type IIa hyperlipidaemia

Not recruiting

Investigational

Study of MK-0616 for Adults with Familial Hypercholesterolemia

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Enlicitide Chloride
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Glycogen storage disease type II

Not recruiting

InvestigationalNo placebo

Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

InvestigationalNo placebo

Germany

Participants:0–17 years
Substances:Cipaglucosidase Alfa
Sponsor:Amicus Therapeutics Inc.

Contact Research Centre

Diabetic retinal oedema+4

Not recruiting

InvestigationalNo placebo

Study on the Safety and Use of AVT06 (Aflibercept) for Patients with Chorioretinal Vascular Diseases

InvestigationalNo placebo

Latvia

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:Alvotech Swiss AG

Contact Research Centre

Gaucher's disease type III+1

Not recruiting

Registered drugNo placebo

Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease Type 3

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Imiglucerase
Sponsor:Genzyme Corp.

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Registered drug

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Registered drug

Austria

Participants:0–17 years · 18–64 years
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Substances studied in this area

The therapies tested most often in Metabolism and nutrition disorders trials.

Semaglutide76 clinical trials Sodium Chloride25 clinical trials Dapagliflozin23 clinical trials Empagliflozin16 clinical trials Cagrilintide15 clinical trials Placebo15 clinical trials Colecalciferol14 clinical trials Tirzepatide13 clinical trials Paracetamol12 clinical trials

Metabolism and nutrition disorders – page 57

Conditions in this area

Clinical trials in Metabolism and nutrition disorders

741 clinical trials

Obesity+1

Study on the Safety and Effects of AZD9550 for Overweight and Obese Patients with Non-Alcoholic Steatohepatitis (NASH) with or without Type 2 Diabetes

Obesity+2

Study of Retatrutide (LY3437943) for Patients with Obesity or Overweight and Knee Osteoarthritis

Type 2 diabetes mellitus+2

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Diabetic retinal oedema

Study on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema

Type 1 diabetes mellitus

Study on the Effects of Siplizumab in Adults with New Onset Type 1 Diabetes

Hyperparathyroidism secondary

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

Hyperparathyroidism secondary

Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

Type IIa hyperlipidaemia

Study of MK-0616 for Adults with Familial Hypercholesterolemia

Glycogen storage disease type II

Study on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease

Diabetic retinal oedema+4

Study on the Safety and Use of AVT06 (Aflibercept) for Patients with Chorioretinal Vascular Diseases

Gaucher's disease type III+1

Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease Type 3

Type 1 diabetes mellitus

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.